Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2012 · 10-Q
Revenue$5.28B$5.28B−41.6% vs Q1 2011 Net Income$1.24B$1.24B+43.8% vs Q1 2011 EPS Diluted$0.78$0.78+41.8% vs Q1 2011 Gross Profit$2,716,000,000−47.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$2,224,930,000+10.6% Free Cash Flowderived$1,771,600,000+9.4% Margins · derivedGross margin51.4%−5.9 pt vs Q1 2011
Operating margin9.6%−4.8 pt vs Q1 2011
Net margin23.5%+14.0 pt vs Q1 2011
ended Mar 31, 2012 · filed May 8, 2012 · 38 d after period end